To scale clinical AI, vendors must design tools that feel natural and personalized to each doctor — otherwise, clinicians won’t use them, said Heidi Health CEO Tom Kelly. In the crowded AI scribe market, he believes that clinician adoption rates, not flashy integration or deployment speeds, are the true measure of success. The post How…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Health tech companies made several major funding announcements in February. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in February appeared first on MedCity News.
A new federal watchdog audit is ratcheting up pressure on government officials to crack down on billions of dollars in overcharges linked to Medicare Advantage home visits. But so far, the Centers for Medicare & Medicaid Services has rejected a recommendation from the Health and Human Services Inspector General to limit payments stemming from house…
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
Lynda Brown-Ganzert is CEO of RxPx. The company is the 2022 merger of the company she founded, Curatio, which was a support system for rare disease patients, with RxMx, a complementary service that helped clinicians manage patients on treatment or clinical trials. Lynda says that somehow I inspired the merger! (Although I don’t remember it,…
This brief provides an overview of premiums and benefits in Medicare Advantage plans that are available for 2026 and key trends over time.
Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company. GSK remains remain the majority shareholder in ViiV, which the pharmaceutical giant formed in partnership with Pfizer in 2009. The post Pfizer Pockets $1.9B by Offloading Stake in HIV Drugs Company Majority-Owned by GSK appeared first…
UH Group replaces its CEO, the payer’s alleged nursing home practices, the future of pharmacy benefit managers, and the healthcare implications of the budget bill are part of the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. The post Debunked Episode 16:…
Health and Human Services Secretary Robert F. Kennedy Jr.’s testimony before the Senate Finance Committee follows the ouster last week of the director of the Centers for Disease Control and Prevention, Susan Monarez. At least four other senior CDC officials resigned in protest. What are the biggest takeaways? What comes next? Tune in for a…